Replies to post #734910 on NorthWest Biotherapeutics Inc (NWBO)

[dstock07734]

wouldn't it be worth their while to lower the price that generic companies couldn't compete?

Gary, I really doubt this would happen. Just see what happened to Abbvie after Humira becomes generic.

https://www.biospace.com/business/abbvies-humira-continues-to-lose-market-share-as-biosimilars-gain-ground-report